Clinical trials
Kidney Failure, Chronic trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 5 |
| Terminated | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| C. R. Bard | 3 |
| Eledon Pharmaceuticals | 3 |
| Sir Charles Gairdner Hospital | 3 |
| The George Institute | 3 |
| Amgen | 2 |
| Cara Therapeutics, Inc. | 2 |
| Eli Lilly and Company | 2 |
| The University of Queensland | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Amicus Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 46 |
| Renal Insufficiency, Chronic | 13 |
| Anemia | 5 |
| Kidney Diseases | 5 |
| Renal Insufficiency | 5 |
| Arteriovenous Fistula | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Hyperphosphatemia | 3 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.